Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, par value $0.004 per share ("Shares")
-
Shares outstanding
-
22,866,677
-
Total 13F shares
-
23,577,228
-
Share change
-
+1,287,056
-
Total reported value
-
$697,847,861
-
Put/Call ratio
-
347%
-
Price per share
-
$29.60
-
Number of holders
-
87
-
Value change
-
+$39,624,167
-
Number of buys
-
31
-
Number of sells
-
41
Institutional Holders of BICYCLE THERAPEUTICS PLC - Common Stock, par value $0.004 per share ("Shares") (BCYC) as of Q4 2022
As of 31 Dec 2022,
BICYCLE THERAPEUTICS PLC - Common Stock, par value $0.004 per share ("Shares") (BCYC) was held by
87 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,577,228 shares.
The largest 10 holders included
Deep Track Capital, LP, Ridgeback Capital Investments L.P., JANUS HENDERSON GROUP PLC, Logos Global Management LP, RTW INVESTMENTS, LP, Paradigm Biocapital Advisors LP, Candriam S.C.A., Point72 Asset Management, L.P., SAMLYN CAPITAL, LLC, and TYBOURNE CAPITAL MANAGEMENT (HK) LTD.
This page lists
87
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.